US Patent Number

10,864,212

Publication Date

12-15-2020

Abstract

The present disclosure relates to compositions and methods for treating retinal damage and/or retinal degradation. More specifically, this disclosure relates to methods for treating degradation of the retinal pigment epithelium by administering compositions comprising a nucleoside and/or a nucleoside or nucleotide reverse transcriptase inhibitor.

Assignees

University of Kentucky Research Foundation, Lexington, KY (US)

Application Number

16/361,810

Filing Date

3-22-2019

Included in

Ophthalmology Commons

Share

COinS